These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36171368)

  • 41. The analysis and distribution of mescaline in postmortem tissues.
    Henry JL; Epley J; Rohrig TP
    J Anal Toxicol; 2003 Sep; 27(6):381-2. PubMed ID: 14516493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.
    Uthaug MV; Davis AK; Haas TF; Davis D; Dolan SB; Lancelotta R; Timmermann C; Ramaekers JG
    J Psychopharmacol; 2022 Mar; 36(3):309-320. PubMed ID: 33949246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HALLUCINOGENS.
    SANDISON RA
    Practitioner; 1964 Jan; 192():30-6. PubMed ID: 14102399
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mescaline, lysergic acid diethylamide (LSD 25) & menstruation].
    SALERNO EV; TALLAFERRO A
    Sem Med; 1957 Jan; 110(2):47-8; passim. PubMed ID: 13421863
    [No Abstract]   [Full Text] [Related]  

  • 45. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.
    CHARALAMPOUS KD; KINROSS-WRIGHT J
    Tex State J Med; 1963 Sep; 59():848-52. PubMed ID: 14054727
    [No Abstract]   [Full Text] [Related]  

  • 47. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.
    Kyzar EJ; Collins C; Gaikwad S; Green J; Roth A; Monnig L; El-Ounsi M; Davis A; Freeman A; Capezio N; Stewart AM; Kalueff AV
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):194-202. PubMed ID: 22251567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
    LUDWIG AM; LEVINE J
    JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
    [No Abstract]   [Full Text] [Related]  

  • 50. SYNTHESIS OF PHENETHYLAMINES RELATED TO MESCALINE AS POSSIBLE PSYCHOTOMIMETIC AGENTS.
    FRIEDMAN OM; PARAMESWARAN KN; BURSTEIN S
    J Med Chem; 1963 May; 6():227-9. PubMed ID: 14185972
    [No Abstract]   [Full Text] [Related]  

  • 51. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
    GERSHON S; OLARIU J
    J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148.
    BALESTRIERI A; FONTANARI D
    AMA Arch Gen Psychiatry; 1959 Sep; 1():279-82. PubMed ID: 13796178
    [No Abstract]   [Full Text] [Related]  

  • 53. THE ENZYMATIC OXIDATIVE DEAMINATION AND EFFECT ON CAT BEHAVIOR MESCALINE AND STRUCTURALLY-RELATED BETA-PHENETHYLAMINES.
    CLARK LC; BENINGTON F; MORIN RD
    Ala J Med Sci; 1964 Oct; 1():417-29. PubMed ID: 14230671
    [No Abstract]   [Full Text] [Related]  

  • 54. [FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
    LEUNER H
    Nervenarzt; 1963 May; 34():198-206. PubMed ID: 14157764
    [No Abstract]   [Full Text] [Related]  

  • 55. CHEMICAL PSYCHOSES.
    HOLLISTER LE
    Annu Rev Med; 1964; 15():203-14. PubMed ID: 14133845
    [No Abstract]   [Full Text] [Related]  

  • 56. The psychology of hallucinogenic drug discontinuers.
    Salzman C; Lieff J; Kochansky GE; Shader RI
    Am J Psychiatry; 1972 Dec; 129(6):755-61. PubMed ID: 4404760
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram.
    APTER JT; PFEIFFER CC
    Ann N Y Acad Sci; 1957 Mar; 66(3):508-13; discussion, 513-4. PubMed ID: 13425239
    [No Abstract]   [Full Text] [Related]  

  • 58. THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA.
    KEELER MH
    N C Med J; 1963 Dec; 24():555-7. PubMed ID: 14089896
    [No Abstract]   [Full Text] [Related]  

  • 59. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.
    HOLLISTER LE; SJOBERG BM
    Compr Psychiatry; 1964 Jun; 5():170-8. PubMed ID: 14156873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.